Crohns & Colitis Foundation Inc
79% goes to programs $9 to raise $100 Thin reserves
Crohns & Colitis Foundation Inc is a 501(c)(3) organization based in New York, New York, registered in 1966, with $85,182,348 in FY2024 revenue. CharityIndex grades it B, and it directs about 79% of spending to programs.
733 3rd Ave Ste 510, New York, NY, 10017 EIN 13-6193105 Since 1966
Revenue (FY2024)
$85.2M
▲ 4.2% vs prior year
Diseases median: $206K
Expenses (FY2024)
$83.5M
Net assets
$3.2M
Employees
—
CharityIndex rating
One independent A+ to F grade from four published criteria, each scored separately from IRS filings and combined by weight.
B
C+Program efficiency40% of the rating79% to programs · $9 to raise $100
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Crohns & Colitis Foundation Inc: 79% to programs · $9 to raise $100 earns a C+ on this criterion. See the exact thresholds →
CFinancial health25% of the rating0 mo reserves · +2% margin
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Crohns & Colitis Foundation Inc: 0 mo reserves · +2% margin earns a C on this criterion. See the exact thresholds →
A+Governance25% of the rating6 of 6 checks met
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Crohns & Colitis Foundation Inc: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
A+Transparency10% of the rating5 of 5 disclosure signals
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Crohns & Colitis Foundation Inc: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Mission
To cure crohn's disease and ulcerative colitis (continued on schedule o)
What they do
The crohn's & colitis foundation provides information and education for the millions of individuals with ibd and their loved ones through a variety of channels at the national and local level including in-person and web-based education, support programs including pediatric and adult focus initiatives, ibd help center answering questions and provding support for those with ibd, and numerous printed materials providingaccurate and up-to-date information. in a recent impact study, over 85% of patients connected with the foundation stated that the foundation has had a positive impact on their ibd journey. these patients also reported better symptom control than non-foundation connected patients. (continued in schedule o)the foundation also offers professional education through our two scientific journals, inflammatory bowel diseases and crohn's & colitis 360, as well as through health professional education programs both in-person and web-based. in addition the foundation hosts the annual crohn's & colitis congress conference. in the past year, the foundation launched a public service awareness campaign to increase familiarity of ibd with the general public and reduce the stigma for those individuals with ibd.
Contact & location
- Address
- 733 3rd Ave Ste 510, New York, NY, 10017
- City
- New York
- State
- New York
- Subcategory
- Digestive & Skin Disorders
- Phone
- …
- Website
- …
Financial trends
Revenue grew from $54.4M (FY2013) to $85.2M (FY2024) across 11 reported years.
Financial snapshot
Financial health & position (FY2024)
Liabilities $47.4MNet assets $3.2M
Operating margin
2.0%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$50.6M
Total liabilities
$47.4M
Net assets
$3.2M
Financials by year
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $85,182,348▲4.2% | $83,504,823▼3.5% | $3,231,669▲64.5% | $50,647,406▼6.2% | 990 |
| 2023 | $81,765,248▲0.3% | $86,537,979▲4.8% | $1,964,810▼67.6% | $54,000,124▼6.0% | 990 |
| 2022 | $81,491,223▲4.4% | $82,569,900▲5.4% | $6,062,850▼46.8% | $57,441,645▼0.4% | 990 |
| 2021 | $78,027,022▲2.4% | $78,323,556▲3.5% | $11,399,994▲3.0% | $57,664,028▲3.7% | 990 |
| 2020 | $76,220,042▲3.1% | $75,670,117▼0.1% | $11,066,493▲25.5% | $55,619,176▲22.8% | 990 |
| 2019 | $73,925,250▲0.1% | $75,723,530▲2.8% | $8,818,349▼2.6% | $45,274,249▼2.8% | 990 |
| 2018 | $73,887,231▼2.6% | $73,648,875▼2.7% | $9,054,773▼14.4% | $46,583,088▼0.4% | 990 |
| 2017 | $75,840,146▲12.7% | $75,664,404▲12.2% | $10,576,858▲0.6% | $46,776,925▲34.3% | 990 |
| 2015 | $67,322,690▲6.5% | $67,453,209▲10.1% | $10,515,576▼4.1% | $34,825,663▲8.8% | 990 |
| 2014 | $63,232,977▲16.2% | $61,241,335▲14.9% | $10,964,882▲20.3% | $32,021,379▲22.2% | 990 |
| 2013 | $54,419,988 | $53,307,072▲3.7% | $9,115,539▲42.4% | $26,203,655▲10.9% | 990 |
| 2012 | — | $51,390,580▲3.6% | $6,400,601▲3.0% | $23,629,249▲2.7% | 990 |
| 2011 | — | $49,604,872▲2.7% | $6,212,574▲14.8% | $23,007,692▲1.0% | 990 |
| 2010 | — | $48,297,842 | $5,412,684 | $22,788,526 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Leadership & compensation (FY2024)
Highest-paid: Michael Osso — $604,255 (0.72% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Michael Osso | President/ceo(non-voting) | 35 | $604,255 |
| Alan Moss | Chief Scientific Officer | 35 | $450,466 |
| Rohit Suri | Chief Technology Officer | 35 | $304,578 |
| Allison Coffey | Chief Development Officer | 35 | $273,205 |
| Sharon Lungrin | Chief Op. Off./chief Fin. | 35 | $267,379 |
| Angela Dobes | Vice President, Ibd Plexus | 35 | $259,396 |
| Marisa Mayer | Chief Legal Officer | 35 | $259,396 |
| Christy Desantis | Chief Mktng. & Comm. Offcr. | 35 | $256,701 |
| Laura Wingate | Chief Edu. Supp. & Advoc. Officer | 35 | $219,544 |
| Chris Fidyk | Evp, Business Development | 35 | $213,952 |
| Sarah Weaver | Vp, Clinical Quality & Innovation | 35 | $206,702 |
| Jack Matarasso | Svp, Digital Marketing | 35 | $202,684 |
| Leana Patel | Vp, People & Culture | 35 | $202,086 |
| Alex Funderburg | Trustee (thru 03/2024) | 1 | — |
| Amber Backhaus | Chairman (as of 03/2024) | 1 | — |
| Andrew Stern | Trustee (as of 03/2024) | 1 | — |
| Annette Martinez | Trustee | 1 | — |
| Armin Rahmanian | Trustee | 1 | — |
| Audra Miller | Trustee | 1 | — |
| Becky Flaherty | Trustee (as of 03/2024) | 1 | — |
Top vendors & contractors (FY2024)
| Contractor | Services | Paid |
|---|---|---|
| Nagarro Inc | Project Support | $2,510,209 |
| Srijan Technologies USA Inc | Web Development Services | $1,686,221 |
| Salesforcecom Inc | Database/it Services | $969,096 |
| Rue Clair Digital LLC DBA Streetlight Di | Marketing Services | $959,576 |
| Deloitte Consulting LLP | It Support | $733,714 |
Grants received · $63.9M total
858 grants to Crohns & Colitis Foundation Inc totaling $63.9M, reported by foundations on their Schedule I filings — showing the 15 most recent.
Grants made · $13.0M in FY2024
75 grants totaling $13.0M in FY2024 — showing the 15 largest. All grants made by Crohns & Colitis Foundation Inc →
| Recipient | Purpose | Amount |
|---|---|---|
| Infinity Biologix LLC | Research | $661,903 |
| Regents of the University of Michigan | Research | $561,992 |
| Weill Medical College of Cornell University | Research | $534,898 |
| Mobius Care Inc | Research | $500,000 |
| Cedars-sinai Medical Center | Research | $426,341 |
| Icahn School of Medicine At Mount Sinai | Research | $407,003 |
| Trustees of the University of Pennsylvania | Research | $388,114 |
| University of North Carolina At Chapel Hill | Research | $384,631 |
| Childrens Hospital Medical Center | Research | $375,023 |
| Mass General Brigham Incorporated | Research | $362,986 |
| Rutgers the State University | Research | $316,168 |
| Aetion Inc | Research | $315,500 |
| Northwestern University | Research | $301,544 |
| Johns Hopkins University | Research | $300,000 |
| Case Western Reserve University | Research | $288,165 |
Similar organizations in Diseases
- Diseases
Fund For Public Health In New York Inc
New York, NY
$96.4M
B+annual revenue
- Diseases
Qsac Inc
New York, NY
$103.6M
Aannual revenue
Diseases
Accesscny Inc
Syracuse, NY
$57.2M
Bannual revenue
Diseases
United Cerebral Palsy Association of Greater Suffolk Inc
Hauppauge, NY
$56.5M
Bannual revenue
Diseases
Ehs Inc
Buffalo, NY
$119.9M
Aannual revenue
Diseases
National Kidney Foundation Inc
New York, NY
$50.1M
Bannual revenue
Diseases
United Cerebral Palsy Association of Nassau County Inc
Roosevelt, NY
$46.1M
Bannual revenue
Diseases
Upstate Cerebral Palsy Inc
Utica, NY
$124.6M
Aannual revenue
Diseases
The Mark Foundation For Cancer Research Us Ltd
New York, NY
$44.8M
A+annual revenue
- Diseases
Center For Disability Services Inc
Albany, NY
$125.8M
A+annual revenue
Compare Crohns & Colitis Foundation Inc
Frequently asked questions
- Is Crohns & Colitis Foundation Inc a legitimate nonprofit?
- Yes. Crohns & Colitis Foundation Inc is a 501(c)(3) organization registered with the U.S. Internal Revenue Service under EIN 13-6193105, based in New York, New York. Donations are tax-deductible.
- What is Crohns & Colitis Foundation Inc's EIN?
- Crohns & Colitis Foundation Inc's Employer Identification Number (EIN) is 13-6193105.
- How much revenue does Crohns & Colitis Foundation Inc report?
- Crohns & Colitis Foundation Inc reported $85,182,348 in total revenue on its fiscal year 2024 IRS Form 990 filing.
- How much of Crohns & Colitis Foundation Inc's spending goes to programs?
- Crohns & Colitis Foundation Inc spends about 79% of its total expenses on programs, based on its latest IRS Form 990.
- What financial grade does Crohns & Colitis Foundation Inc have?
- CharityIndex grades Crohns & Colitis Foundation Inc B, based on program efficiency and fundraising cost.
- How much does Crohns & Colitis Foundation Inc's highest-paid employee make?
- The highest reported compensation on Crohns & Colitis Foundation Inc's latest Form 990 is $604,255, paid to Michael Osso (President/ceo(non-voting)).
More nonprofits in New York
Explore more
Data for Crohns & Colitis Foundation Inc (EIN 13-6193105) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.